These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 18997051

  • 1. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
    Neumann DR, Obuchowski NA, Difilippo FP.
    J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 'Low dose' 99mTc-Sestamibi for radioguided surgery of primary hyperparathyroidism.
    Rubello D, Piotto A, Medi F, Gross MD, Shapiro B, Erba P, Mariani G, Pelizzo MR, Italian Study Group on Radioguided Surgery and ImmunoScintigraphy.
    Eur J Surg Oncol; 2005 Mar; 31(2):191-6. PubMed ID: 15698737
    [Abstract] [Full Text] [Related]

  • 4. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
    Neumann DR, Esselstyn CB, Go RT, Wong CO, Rice TW, Obuchowski NA.
    AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR, Esselstyn CB, Madera A, Wong CO, Lieber M.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [Abstract] [Full Text] [Related]

  • 8. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism.
    Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF.
    Clin Radiol; 2010 Apr; 65(4):278-87. PubMed ID: 20338394
    [Abstract] [Full Text] [Related]

  • 9. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements.
    Sfakianakis GN, Irvin GL, Foss J, Mallin W, Georgiou M, Deriso GT, Molinari AS, Ezuddin S, Ganz W, Serafini A, Jabir AM, Chandarlapaty SK.
    J Nucl Med; 1996 May; 37(5):798-804. PubMed ID: 8965148
    [Abstract] [Full Text] [Related]

  • 10. Sestamibi/iodine subtraction single photon emission computed tomography in reoperative secondary hyperparathyroidism.
    Neumann DR, Esselstyn CB, Madera AM.
    Surgery; 2000 Jul; 128(1):22-8. PubMed ID: 10876181
    [Abstract] [Full Text] [Related]

  • 11. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
    Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, Ochoa BB, Moxley DM, Erwin WD, Podoloff DA.
    J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
    [Abstract] [Full Text] [Related]

  • 12. Dual-isotope 99mTc-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT/CT and pinhole planar scan.
    Hassler S, Ben-Sellem D, Hubele F, Constantinesco A, Goetz C.
    Clin Nucl Med; 2014 Jan; 39(1):32-6. PubMed ID: 24152647
    [Abstract] [Full Text] [Related]

  • 13. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L, Luo Q, Shen Y, Yu Y, Yuan Z, Lu H, Zhu R.
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [Abstract] [Full Text] [Related]

  • 14. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS.
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [Abstract] [Full Text] [Related]

  • 15. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients.
    Serra A, Bolasco P, Satta L, Nicolosi A, Uccheddu A, Piga M.
    Radiol Med; 2006 Oct; 111(7):999-1008. PubMed ID: 17021682
    [Abstract] [Full Text] [Related]

  • 16. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
    Lorberboym M, Minski I, Macadziob S, Nikolov G, Schachter P.
    J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
    [Abstract] [Full Text] [Related]

  • 17. Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism.
    Wang TS, Cheung K, Farrokhyar F, Roman SA, Sosa JA.
    Surgery; 2011 Dec; 150(6):1286-94. PubMed ID: 22136852
    [Abstract] [Full Text] [Related]

  • 18. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
    Schalin-Jäntti C, Ryhänen E, Heiskanen I, Seppänen M, Arola J, Schildt J, Väisänen M, Nelimarkka L, Lisinen I, Aalto V, Nuutila P, Välimäki MJ.
    J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
    [Abstract] [Full Text] [Related]

  • 19. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.
    Wang H, Fu HL, Li JN, Zou RJ, Gu ZH, Wu JC.
    Clin Imaging; 2009 May; 33(1):49-54. PubMed ID: 19135930
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid Imaging with Simultaneous Acquisition of 99mTc-Sestamibi and 123I: The Relative Merits of Pinhole Collimation and SPECT/CT.
    Bhatt PR, Klingensmith WC, Bagrosky BM, Walter JC, McFann KK, McIntyre RC, Raeburn CD, Koo PJ.
    J Nucl Med Technol; 2015 Dec; 43(4):275-81. PubMed ID: 26584615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.